Heart Disease News and Research

Latest Heart Disease News and Research

Stereotaxis reports first-ever use of Niobe Magnetic Navigation System to treat hypertension

Stereotaxis, Inc. announced today the first-ever use of its Niobe® Magnetic Navigation System in a renal artery ablation procedure for the treatment of chronic hypertension that was not treatable with medication.

24 Feb 2011

UK HealthCare to deploy Allscripts EHR, Practice Management solution for faculty providers

UK HealthCare, the patient care operations of University of Kentucky, will deploy the Allscripts lectronic Health Record and Practice Management solution to help its team of 6,000 physicians, nurses, pharmacists and health care providers enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.

24 Feb 2011

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.

24 Feb 2011

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

Opsens Inc. said today that its Medical Division has reached a significant milestone, successfully completing a pre-clinical animal study on the EasyWire device, designed to measure Fractional Flow Reserve in the evaluation of coronary lesions.

24 Feb 2011

Refrigerated whole blood may have shelf life beyond current standard of 24 to 48 hours

In a finding that may potentially improve survival from war injuries and disasters, laboratory researchers report that refrigerated whole blood may have a shelf life well beyond the current standard of 24 to 48 hours.

24 Feb 2011

Study: Newborn screening for hemoglobin H disease can reduce mortality rate

A new and groundbreaking study conducted by Children's Hospital & Research Center Oakland hematologists is the first of its type to examine the natural history of heritable blood disorder hemoglobin H (HbH) which is on the rise in the United States.

24 Feb 2011

BRI and Eureka Genomics form strategic alliance to advance cancer treatments

Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and bioinformatics pioneer Eureka Genomics (EG) have formed a strategic alliance to achieve a better understanding of the causes of colorectal cancer, potentially leading to advancements in the disease's prevention, management and treatment.

24 Feb 2011

Excess weight contributes to higher risk of death in Asians

A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.

24 Feb 2011

Progeria-derived iPS cells may treat aging-related disease in children

The current pace of population aging is without parallel in human history but surprisingly little is known about the human aging process, because lifespans of eight decades or more make it difficult to study. Now, researchers at the Salk Institute for Biological Studies have replicated premature aging in the lab, allowing them to study aging-related disease in a dish.

24 Feb 2011

Scientists find bovine colostrum can massively reduce leaky gut syndrome

Scientists investigating natural ways to enhance athletic performance have found that bovine colostrum can massively reduce gut permeability - otherwise known as 'leaky gut syndrome.'

24 Feb 2011

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced that its LipiScan™ IVUS Coronary Imaging System will be featured in several presentations during the annual Cardiovascular Research Technologies (CRT) 2011 meeting, being held February 27 through March 1, 2011 at the Omni Shoreham Hotel in Washington, D.C.

24 Feb 2011

Scientists suggest new vitamin D-fortified bread can solve insufficiency problem

With most people unable to get enough vitamin D from sunlight or foods, scientists are suggesting that a new vitamin D-fortified food - bread made with high-vitamin D yeast - could fill that gap. Their study, confirming that the approach works in laboratory tests, appears in ACS' Journal of Agricultural and Food Chemistry.

24 Feb 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

ACT receives patent for its single-blastomere technology

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has been issued a patent on its "single-blastomere" technique. Patent Number 7,893,315 broadly covers ACT's proprietary single-blastomere technology that provides a non-destructive alternative for deriving human embryonic stem cell lines.

23 Feb 2011

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.

23 Feb 2011

Ibio acquires Orphan Drug Designation and Fabry disease therapeutic program from Kentucky

iBio, Inc. today announced it has acquired Orphan Drug Designation for plant-produced human alpha galactosidase A and related property rights from an affiliate of Kentucky Bioprocessing LLC and has initiated a program, based on its iBioLaunch platform, to develop an improved version of the enzyme for therapy of Fabry disease.

23 Feb 2011

Biological pathways in PTSD revealed: Study

Up to 20% of the population exposed to a horror of a war, trauma or abuse may go on to develop post-traumatic stress disorder. PTSD, as it is better known, is a debilitating psychiatric disorder marked by flashbacks and nightmares. Till date the biological basis for PTSD was unclear. But a new study offers clues about why some people rebound from horrific events while others relive them, and may lead to predictive tests and even treatments.

23 Feb 2011

Versatile ultra-low power biomedical signal processor

At today’s International Solid-State Circuit Conference (ISSCC2011), imec, Holst Centre and NXP present a versatile ultra-low power biomedical signal processor, CoolBioTM, meeting the requirements of future wearable biomedical sensor systems. The biomedical signal processor consumes only 13pJ/cycle when running a complex ECG (electrocardiogram) algorithm at 1MHz and 0.4V operating voltage. This C-programmable chip is voltage and performance scalable supporting a frequency range of 1MHz up to 100MHz with an operating voltage from 0.4 to 1.2V.

23 Feb 2011

Tips for heart healthiness

Everyone should know the warning signs for a heart attack -- but according to Dr. Isaac Eliaz, effective prevention requires much more than a list of potential symptoms.

23 Feb 2011

Brain reward center responds to good and bad experiences

The so-called reward center of the brain may need a new name, say scientists who have shown it responds to good and bad experiences. The finding, published in PLoS One, may help explain the "thrill" of thrill-seeking behavior or maybe just the thrill of surviving it, according to scientists at Georgia Health Sciences University and East China Normal University.

23 Feb 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Stereotaxis reports first-ever use of Niobe Magnetic Navigation System to treat hypertension

UK HealthCare to deploy Allscripts EHR, Practice Management solution for faculty providers

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

Refrigerated whole blood may have shelf life beyond current standard of 24 to 48 hours

Study: Newborn screening for hemoglobin H disease can reduce mortality rate

BRI and Eureka Genomics form strategic alliance to advance cancer treatments

Excess weight contributes to higher risk of death in Asians

Progeria-derived iPS cells may treat aging-related disease in children

Scientists find bovine colostrum can massively reduce leaky gut syndrome

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

Scientists suggest new vitamin D-fortified bread can solve insufficiency problem

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

ACT receives patent for its single-blastomere technology

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Ibio acquires Orphan Drug Designation and Fabry disease therapeutic program from Kentucky

Biological pathways in PTSD revealed: Study

Versatile ultra-low power biomedical signal processor

Tips for heart healthiness

Brain reward center responds to good and bad experiences

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in